FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

2891711000001108: OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17338501000001119 OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54153301000001114 OxyContin 10mg modified-release tablets (Napp Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Is a Oxycodone hydrochloride 10mg m/r tablet false Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Is a OxyContin true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Is a Oxycodone 10mg modified-release tablets false Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Is a Oxycodone 10mg modified-release tablets true Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is pack of False OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP True OxyContin 10mg tablets (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start